Aerovate Therapeutics Aktie
ISIN: US0080642061
01.07.2025 15:15:48
|
Jade Biosciences Names Brad Dahms As CFO
(RTTNews) - Jade Biosciences, Inc. (JBIO), a biotechnology company, on Tuesday announced that it has appointed Brad Dahms as Chief Financial Officer.
Dahms was most recently the Chief Financial Officer and Chief Business Officer of IDRx. Dahms had also worked at Theseus Pharmaceuticals as CFO.
On Monday, Jade Bioscience closed trading, 8.71% higher at $9.99 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Aerovate Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Aerovate Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Aerovate Therapeutics Inc Registered Shs | 7,84 | -5,31% |
|